Informations:
Erreur:
ID
31433
Description
DC Vaccine Therapy Combined With Cytokine-Induced Killer Cell in Treating Patients With Renal Cell Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT00862303
Lien
https://clinicaltrials.gov/show/NCT00862303
Mots-clés
Versions (1)
- 21/08/2018 21/08/2018 - Sarah Riepenhausen
Détendeur de droits
Fuzhou General Hospital
Téléchargé le
21 août 2018
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY-NC 3.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Renal Cell Carcinoma NCT00862303
Eligibility Renal Cell Carcinoma NCT00862303
- StudyEvent: Eligibility
Similar models
Eligibility Renal Cell Carcinoma NCT00862303
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Type de données
Alias
Histological determination of a renal cell carcinoma
Item
histologically proven renal cell carcinoma
boolean
C0449575 (UMLS CUI [1,1])
C0007134 (UMLS CUI [1,2])
C0007134 (UMLS CUI [1,2])
Age
Item
age: > 18
boolean
C0001779 (UMLS CUI [1])
ECOG perfomance status
Item
who- ecog performance status 0-1
boolean
C1520224 (UMLS CUI [1])
Measurable tumor lesions according to the recist criteria
Item
at least one measurable tumor lesions according to the recist criteria.
boolean
C1709926 (UMLS CUI [1,1])
C1513041 (UMLS CUI [1,2])
C1513041 (UMLS CUI [1,2])
Life expectancy
Item
life expectancy more than 3 months
boolean
C0023671 (UMLS CUI [1])
Informed Consent
Item
written informed consent
boolean
C0021430 (UMLS CUI [1])
History of another neoplastic disease
Item
patients with a history of any other neoplastic disease less than 5 years ago (excepting treated carcinomas in situ of the cervix and basal/squamous cell carcinomas of the skin).
boolean
C2735087 (UMLS CUI [1])
CNS metastasis
Item
patients with metastatic disease in the central nervous system (cns).
boolean
C0686377 (UMLS CUI [1])
Concomitant significant illness
Item
patients with other significant illness including severe allergy, asthma, angina pectoris or congestive heart failure.
boolean
C0243087 (UMLS CUI [1])
C2945656 (UMLS CUI [2])
C0004096 (UMLS CUI [3])
C0002962 (UMLS CUI [4])
C0018802 (UMLS CUI [5])
C2945656 (UMLS CUI [2])
C0004096 (UMLS CUI [3])
C0002962 (UMLS CUI [4])
C0018802 (UMLS CUI [5])
Acute or chronic infection
Item
patients with acute or chronic infection including hiv.
boolean
C3714514 (UMLS CUI [1])
C0019682 (UMLS CUI [2])
C0019682 (UMLS CUI [2])
Pregnancy or breast feeding
Item
patients who are pregnant or nursing.
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0006147 (UMLS CUI [2])
Prior antineoplastic therapy
Item
patients who have received antineoplastic therapy including chemotherapy or immunotherapy less than 4 weeks before beginning the trial.
boolean
C2346834 (UMLS CUI [1])
Corticoid or immunosuppressive therapy
Item
patients who receive corticosteroids or other immunosuppressive agents.
boolean
C0021079 (UMLS CUI [1])
C0239126 (UMLS CUI [2])
C0239126 (UMLS CUI [2])
Concomitant autoimmune diseases
Item
patients with active autoimmune diseases such as lupus erythematosus, rheumatoid arthritis or thyroiditis.
boolean
C0004364 (UMLS CUI [1])
C0409974 (UMLS CUI [2])
C0003873 (UMLS CUI [3])
C0920350 (UMLS CUI [4])
C0409974 (UMLS CUI [2])
C0003873 (UMLS CUI [3])
C0920350 (UMLS CUI [4])